Belite Bio Inc ADR (BLTE) had the highest return between June 10, 2022 and June 30, 2022 by a mid-cap US stock, returning 87.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Belite Bio Inc ADR (BLTE) | 6/10/2022 - 6/30/2022 | 87.93% |
Axsome Therapeutics (AXSM) | 6/10/2022 - 6/30/2022 | 51.32% |
PTC Therapeutics (PTCT) | 6/10/2022 - 6/30/2022 | 47.44% |
Nuvalent (NUVL) | 6/10/2022 - 6/30/2022 | 42.29% |
Centessa Pharmaceuticals PLC ADR (CNTA) | 6/10/2022 - 6/30/2022 | 33.79% |
Miniso Group Holding (MNSO) | 6/10/2022 - 6/30/2022 | 32.38% |
Viking Therapeutics (VKTX) | 6/10/2022 - 6/30/2022 | 30.18% |
Amicus Therapeutics (FOLD) | 6/10/2022 - 6/30/2022 | 28.78% |
Zai Lab (ZLAB) | 6/10/2022 - 6/30/2022 | 27.73% |
BridgeBio Pharma (BBIO) | 6/10/2022 - 6/30/2022 | 25.41% |
Kymera Therapeutics (KYMR) | 6/10/2022 - 6/30/2022 | 24.94% |
New Oriental Education & Technology (EDU) | 6/10/2022 - 6/30/2022 | 24.07% |
Denali Therapeutics (DNLI) | 6/10/2022 - 6/30/2022 | 23.76% |
HUTCHMED DRC (HCM) | 6/10/2022 - 6/30/2022 | 22.48% |
Celcuity LLC (CELC) | 6/10/2022 - 6/30/2022 | 22.15% |
Legend Biotech (LEGN) | 6/10/2022 - 6/30/2022 | 21.47% |
Veracyte (VCYT) | 6/10/2022 - 6/30/2022 | 20.53% |
TransMedics (TMDX) | 6/10/2022 - 6/30/2022 | 19.58% |
ELF Beauty (ELF) | 6/10/2022 - 6/30/2022 | 19.42% |
Ultragenyx (RARE) | 6/10/2022 - 6/30/2022 | 18.8% |
Coty (COTY) | 6/10/2022 - 6/30/2022 | 17.79% |
Jfrog (FROG) | 6/10/2022 - 6/30/2022 | 17.25% |
Agios Pharm (AGIO) | 6/10/2022 - 6/30/2022 | 17.24% |
Vaxcyte (PCVX) | 6/10/2022 - 6/30/2022 | 16.86% |
Hims Hers Health (HIMS) | 6/10/2022 - 6/30/2022 | 16.15% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
